MX2022015802A - Construcciones de anellovirus en tandem. - Google Patents
Construcciones de anellovirus en tandem.Info
- Publication number
- MX2022015802A MX2022015802A MX2022015802A MX2022015802A MX2022015802A MX 2022015802 A MX2022015802 A MX 2022015802A MX 2022015802 A MX2022015802 A MX 2022015802A MX 2022015802 A MX2022015802 A MX 2022015802A MX 2022015802 A MX2022015802 A MX 2022015802A
- Authority
- MX
- Mexico
- Prior art keywords
- anellovirus
- tandem
- constructs
- nucleic acid
- acid construct
- Prior art date
Links
- 241001339993 Anelloviridae Species 0.000 title abstract 4
- 239000012636 effector Substances 0.000 abstract 2
- 150000007523 nucleic acids Chemical class 0.000 abstract 2
- 102000039446 nucleic acids Human genes 0.000 abstract 2
- 108020004707 nucleic acids Proteins 0.000 abstract 2
- 239000012634 fragment Substances 0.000 abstract 1
- 230000002068 genetic effect Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/0008—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition
- A61K48/0025—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition wherein the non-active part clearly interacts with the delivered nucleic acid
- A61K48/0041—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition wherein the non-active part clearly interacts with the delivered nucleic acid the non-active part being polymeric
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/00021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/00041—Use of virus, viral particle or viral elements as a vector
- C12N2750/00043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/00041—Use of virus, viral particle or viral elements as a vector
- C12N2750/00044—Chimeric viral vector comprising heterologous viral elements for production of another viral vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/00051—Methods of production or purification of viral material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/00071—Demonstrated in vivo effect
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063038483P | 2020-06-12 | 2020-06-12 | |
| US202163146963P | 2021-02-08 | 2021-02-08 | |
| PCT/US2021/037091 WO2021252955A1 (en) | 2020-06-12 | 2021-06-11 | Tandem anellovirus constructs |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2022015802A true MX2022015802A (es) | 2023-03-28 |
Family
ID=78845951
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2022015802A MX2022015802A (es) | 2020-06-12 | 2021-06-11 | Construcciones de anellovirus en tandem. |
Country Status (12)
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3121528A1 (en) | 2018-12-12 | 2020-06-18 | Flagship Pioneering Innovations V, Inc. | Anellosomes and methods of use |
| TW202529819A (zh) | 2023-10-13 | 2025-08-01 | 美商旗艦先鋒創新公司 | 組織特異性指環載體(anellovector)遞送 |
| WO2025160409A1 (en) | 2024-01-26 | 2025-07-31 | Flagship Pioneering Innovations V, Inc. | Viral vectors for modulating vegf function |
| CN119331914A (zh) * | 2024-10-17 | 2025-01-21 | 中科开浦生物科技(湖北)有限公司 | 一种指环病毒感染性克隆的构建方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2593189B1 (fr) * | 1986-01-22 | 1989-10-20 | Pasteur Institut | Nouveau retrovirus susceptible de provoquer le sida, antigenes obtenus a partir de ce retrovirus et anticorps correspondants et leurs applications au diagnostic du sida |
| RU2553223C2 (ru) * | 2009-08-21 | 2015-06-10 | Виргиния Тек Интеллекчуал Пропертиз, Инк. | ВАКЦИНЫ НА ОСНОВЕ СВИНОГО ВИРУСА Torque teNO И СПОСОБЫ ДИАГНОСТИКИ ИНФЕКЦИЙ, ВЫЗВАННЫХ ЭТИМ ВИРУСОМ |
| ES2777217T3 (es) * | 2013-06-17 | 2020-08-04 | Broad Inst Inc | Suministro, modificación y optimización de sistemas de guía en tándem, métodos y composiciones para la manipulación de secuencias |
| RU2744193C2 (ru) * | 2015-10-16 | 2021-03-03 | Канзас Стейт Юниверсити Рисерч Фаундейшн | Иммуногенные композиции для иммунизации свиней против цирковируса типа 3 и способы их получения и применения |
| CA3066750A1 (en) * | 2017-06-13 | 2018-12-20 | Flagship Pioneering Innovations V, Inc. | Compositions comprising curons and uses thereof |
| CA3121528A1 (en) * | 2018-12-12 | 2020-06-18 | Flagship Pioneering Innovations V, Inc. | Anellosomes and methods of use |
| JP2022513459A (ja) * | 2018-12-12 | 2022-02-08 | フラッグシップ パイオニアリング イノベーションズ ブイ, インコーポレイテッド | タンパク質代替治療モダリティを送達するためのアネロソーム |
| EP3894567A2 (en) * | 2018-12-12 | 2021-10-20 | Flagship Pioneering Innovations V, Inc. | Anellosomes for delivering intracellular therapeutic modalities |
-
2021
- 2021-06-11 AU AU2021288320A patent/AU2021288320A1/en not_active Abandoned
- 2021-06-11 CA CA3186894A patent/CA3186894A1/en active Pending
- 2021-06-11 IL IL298978A patent/IL298978A/en unknown
- 2021-06-11 KR KR1020237001349A patent/KR20230036110A/ko not_active Ceased
- 2021-06-11 CN CN202180057194.7A patent/CN116075591A/zh active Pending
- 2021-06-11 EP EP21822876.5A patent/EP4165198A4/en not_active Withdrawn
- 2021-06-11 WO PCT/US2021/037091 patent/WO2021252955A1/en not_active Ceased
- 2021-06-11 TW TW110121557A patent/TW202223095A/zh unknown
- 2021-06-11 BR BR112022025190A patent/BR112022025190A2/pt unknown
- 2021-06-11 US US18/009,557 patent/US20230348933A1/en not_active Abandoned
- 2021-06-11 MX MX2022015802A patent/MX2022015802A/es unknown
- 2021-06-11 JP JP2022576004A patent/JP2023530278A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| IL298978A (en) | 2023-02-01 |
| WO2021252955A1 (en) | 2021-12-16 |
| US20230348933A1 (en) | 2023-11-02 |
| CN116075591A (zh) | 2023-05-05 |
| KR20230036110A (ko) | 2023-03-14 |
| EP4165198A4 (en) | 2024-10-23 |
| TW202223095A (zh) | 2022-06-16 |
| AU2021288320A1 (en) | 2023-01-19 |
| EP4165198A1 (en) | 2023-04-19 |
| BR112022025190A2 (pt) | 2023-03-07 |
| CA3186894A1 (en) | 2021-12-16 |
| JP2023530278A (ja) | 2023-07-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11396665B2 (en) | CRISPR-CAS system for a filamentous fungal host cell | |
| CL2021002741A1 (es) | Una proteína crispr de prevotella y francisella 1 (cpf1) aislada de lachnospiraceae bacterium nd2006; proteína de fusión que la comprende; ácido nucleico; vector; métodos para alterar el genoma de una célula o una molécula de adn bicatenario in vitro que utilizan dichas proteínas (divisional de sol. 201903004) | |
| AU2021311773A8 (en) | Novel, non-naturally occurring CRISPR-CAS nucleases for genome editing | |
| MX2022015208A (es) | Constructos de acido nucleico para fabricacion de proteinas. | |
| NO20075088L (no) | Vertscelle omfattende en vektor for fremstilling av proteiner som krever gamma-karboksylering | |
| MX2010008052A (es) | Plantas que tienen rasgos aumentados relacionados con el rendimiento y un metodo para obtenerlas. | |
| ATE440950T1 (de) | Konstrukte und verfahren zur regulation der genexpression | |
| WO2006136831A3 (en) | Gene expression technique | |
| DE60237067D1 (de) | N verwendung | |
| WO2022074037A3 (en) | Alpha-amylase variants | |
| CY1118989T1 (el) | Μεθοδος για την παραγωγη πρωτεϊνης | |
| MX2025008671A (es) | Metodo de cultivo de plantas resistentes a la mancha gris de la hoja | |
| WO2022008510A3 (en) | Intron-encoded extranuclear transcripts for protein translation, rna encoding, and multi-timepoint interrogation of non-coding or protein-coding rna regulation | |
| BR112022025190A2 (pt) | Construtos de anellovirus em tandem | |
| MX2023001397A (es) | Variantes de fitasa y polinucleotidos que codifican las mismas. | |
| GB2458419A (en) | Vector for expressing NC protein of HIV and method for producing NC protein using the same | |
| WO2023039534A3 (en) | Compositions comprising a cas12i polypeptide and uses thereof | |
| WO2023036970A3 (en) | Novel lytic polysaccharide monooxygenase and uses thereof | |
| MX2022006748A (es) | Composiciones de acidos nucleicos. | |
| WO2024192268A3 (en) | Anellovirus constructs comprising recombination sites and cross-packaging of anellovector particles and genetic elements | |
| MX2010004699A (es) | Plantas que tienen rasgos incrementados relacionados con el rendimiento y un metodo para producirlas. | |
| US10450575B2 (en) | Increasing the expression of a transgene in eukaryotic cells by reducing RNA interference | |
| WO2021202443A8 (en) | Compositions and methods for silencing dnajc15 gene expression | |
| ATE445009T1 (de) | Signalpeptid zur herstellung eines polypeptids | |
| JOP20240240A1 (ar) | حمض نووي معزول يشفر بروتين اندماج قائم على fviii-bdd وعلى ببتيد إشارة غير متجانس |